Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyL
US10947197B2 · kind B2 · utility
1Cited by
2References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2017 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Jun 9, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods, and related compositions, for the improved synthesis of [18F]DCFPyL are disclosed. Also provided are methods, and related compositions, for the use of [18F]DCFPyL so produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.